A Hyderabad techie and Chennai researcher come up with AI-powered tech to test COVID-19 in 20 seconds

• A test developed by a University of Dayton researcher can detect the presence of COVID-19 in a chest X-rays with 96% accuracy.
  
• The patent is licences to a South Carolina based IT company called Blue Eye Soft.
  
• Blue Eye Soft’s CEO Kodeboyina and his team are now planning to submit a full proposal to the US Food and Drug Administration for approval.
  
• According to reports, the AI-powered system developed by Narayanan uses a deep learning algorithm that searches for markings on X-rays that indicate the presence of Coronavirus.
  

Two Indian Americans came up with an AI-powered advanced diagnostic system which can detect the COVID-19 virus in less than 20 seconds, according to reports from TOI.

The technology — from the University of Dayton can detect the presence of COVID-19 in chest X-rays with 96% accuracy. This was adapted from existing medical diagnostic software, University of Dayton Research Institute (UDRI) said.

The system is AI-powered and uses a deep learning algorithm that searches for markings on X-rays that indicate the presence of Coronavirus.

The university said that the software which their researcher Barath Narayanan came up with, has been exclusively licensed to a company called Blue Eye Soft. The president and CEO of the company is yet another Indian from Hyderabad, Srikanth Kodeboyina.

Barath who hails from Chennai, is a research scientist at UDRI and an adjunct faculty. Both of them had gone to the US to pursue higher studies long back. Srikanth later became the head of Blue Eye Soft, a South Carolina based IT software solutions company.

Kodeboyina and his team are now planning to submit a full proposal to the US Food and Drug Administration for approval “within a matter of days” UDRI said in a release.

The company has already filed a provisional patent. “I am now rushing through the FDA approval process,” Kodeboyina told TOI from the US. “Every life matters, so for the next few days, I am focussed on getting necessary certification from international boards,” he said.

“I will be thrilled once FDA approval comes,” Barath told TOI.

SEE ALSO: Paytm makes its insurance debut with a Covid-19 plan that will cover loss of pay during quarantine
Coronavirus News and Updates
What are the Coronavirus symptoms and how to check for them at home